Identification of novel Leishmania major antigens that elicit IgG2a response in resistant and susceptible mice.
- Author:
Mohammad Reza MOHAMMADI
1
;
Majid ZEINALI
;
Sussan K ARDESTANI
;
Amina KARIMINIA
Author Information
- Publication Type:Original Article ; Comparative Study ; Research Support, Non-U.S. Gov't
- Keywords: Leishmania major; leishmaniasis; antigen; IgG2a; IgG1; metacyclic promastigotes; mouse; man
- MeSH: Protozoan Proteins/immunology/*isolation & purification; Mice, Inbred C57BL; Mice, Inbred BALB C; Mice; Life Cycle Stages/immunology; Leishmaniasis, Cutaneous/immunology; Leishmania major/*immunology; Immunoglobulin G/*biosynthesis/blood; Humans; Female; Blotting, Western/methods; Antigens, Protozoan/immunology/*isolation & purification; Animals
- From:The Korean Journal of Parasitology 2006;44(1):43-48
- CountryRepublic of Korea
- Language:English
- Abstract: Experimental murine models with high, intermediate and low levels of genetically based susceptibility to Leishmania major infection reproduce almost entire spectrum of clinical manifestations of the human disease. There are increasing non-comparative studies on immune responses against isolated antigens of L. major in different murine strains. The aim of the present study was to find out whether there is an antigen that can induce protective immune response in resistant and susceptible murine strains. To do that, crude antigenic extract of procyclic and metacyclic promastigotes of L. major was prepared and subjected to SDS-PAGE electrophoresis. Western-blotting was used to search for antigen(s) capable of raising high antibody level of IgG2a versus IgG1 in the sera of both infected resistant and susceptible strains. Two novel antigens from metacyclic promastigotes of L. major (140 and 152 kDa) were potentially able to induce specific dominant IgG2a responses in BALB/c and C57BL/6 mice. The 2 antigens also reacted with IgG antibody of cutaneous leishmaniasis patients. We confirm that 140 and 152 kDa proteins of L. major promastigotes are inducing IgG production in mice and humans.
